1218. Activity of Meropenem-Vaborbactam and Comparator Agents Against Carbapenemase-Negative, Carbapenem-Resistant Enterobacterales from US Hospitals

BACKGROUND: Meropenem-vaborbactam (MVB) is an important addition to the armamentarium to treat infections caused by carbapenem-resistant Enterobacterales (CREs). Carbapenemase-negative (CN) CRE isolates have been reported, but the activity of newer agents against these isolates is still not well und...

Descripción completa

Detalles Bibliográficos
Autores principales: Castanheira, Mariana, Doyle, Timothy B, Kantro, Valerie, Mendes, Rodrigo E, Shortridge, Dee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643857/
http://dx.doi.org/10.1093/ofid/ofab466.1410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643857/
http://dx.doi.org/10.1093/ofid/ofab466.1410

Ejemplares similares